СДЕЛАНО В РОССИИ
МЕЖДУНАРОДНЫЙ ЭКСПОРТНЫЙ ФОРУМ
21 ОКТЯБРЯ 2025Г.
Москва, Национальный центр "Россия"
Регистрация открыта до 13.10.25
ABOUT THE COMPANY
Pharmasyntez is one of the largest manufacturers of socially significant medicines in Russia. Its product portfolio includes over 300 drug names and more than 60 pharmaceutical substances. Key therapeutic areas include tuberculosis, HIV, oncology, diabetes and hepatitis.
The company's production capabilities are represented by five modern high-tech plants located in Irkutsk, Ussuriysk, Saint Petersburg, Bratsk and Tyumen.
In-house API (Active Pharmaceutical Ingredient) production.
All dosage forms: tablets, capsules, granules, infusion solutions, sterile powders and injectable solutions.
In-house API (Active Pharmaceutical Ingredient) production.
All dosage forms: tablets, capsules, granules, infusion solutions, sterile powders and injectable solutions.
Saterex® (INN Gozoglipton) – an innovative drug for the treatment of type 2 diabetes from the DPP-4 inhibitor class.
Original drug; highly demanded class of DPP-IV inhibitors, which address seven of the eleven pathogenetic components of type 2 diabetes.
Easy of use – once-a-day treatment regimen.
Effective as monotherapy (HbA1c reduction by 0.93%) and in combination with Metformin (HbA1c reduction by 1.3%).
Minimal risk of hypoglycemia.
Comparable clinical efficacy and safety to other drugs in its class but at a significantly lower price compared to foreign analogs.
Easy of use – once-a-day treatment regimen.
Effective as monotherapy (HbA1c reduction by 0.93%) and in combination with Metformin (HbA1c reduction by 1.3%).
Minimal risk of hypoglycemia.
Comparable clinical efficacy and safety to other drugs in its class but at a significantly lower price compared to foreign analogs.
СДЕЛАНО
В РОССИИ 2023
В РОССИИ 2023
МЕЖДУНАРОДНЫЙ ЭКСПОРТНЫЙ ФОРУМ
© 2024. Все права защищены
+7 (499) 495-12-03